TVMR With the INNOVALVE System Trial - Early Feasibility Study
Start Date
9/1/2022
Completion Date
7/1/2031
Summary
Study to evaluate the safety and performance of the INNOVALVE system
Detailed Description
The study is a multi-center, First-In-Human, prospective, single arm early feasibility study to evaluate the safety and performance of the INNOVALVE system
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
INNOVALVE system
Conditions
Locations
Cedars-Sinai
Los Angeles, California 90048
United States
Stanford University
Palo Alto, California 94305
United States
Naples Comprehensive Health
Naples, Florida 34102
United States
Emory University
Atlanta, Georgia 30308
United States
Piedmont Heart Institute
Atlanta, Georgia 30309
United States
Northwestern
Chicago, Illinois 60611
United States
University of Michigan Hospital and Health Systems
Ann Arbor, Michigan 48109
United States
Mayo Clinic
Rochester, Minnesota 555905
United States
Saint Luke's Hospital
Kansas City, Missouri 64111
United States
Morristown Medical Center
Morristown, New Jersey 07960
United States
Northwell Health
Manhasset, New York 11030
United States
Cornell
New York, New York 10021
United States
NewYork-Presbyterian / Columbia University
New York, New York 10032
United States
Cleveland Clinic
Cleveland, Ohio 44195
United States
OhioHealth Research Institute
Columbus, Ohio 43214
United States
Oregon Health & Science Universtiy
Portland, Oregon 97239
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
Vanderbilt University Medical Center
Nashville, Tennessee 37203
United States
Ascension Saint Thomas
Nashville, Tennessee 37205
United States
Swedish Medical Center
Seattle, Washington 98122
United States